Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.302, 2001-01, pp. : 11-11
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Substantial delays in US infant vaccinations: better late than never?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 474, 2005-01 ,pp. :
Substantial delays in US infant vaccinations: better late than never?
Inpharma, Vol. 1, Iss. 1479, 2005-01 ,pp. :
The return of Tysabri to the market in the US?
Inpharma, Vol. 1, Iss. 1529, 2006-01 ,pp. :
Moxifloxacin a better option for AECB than levofloxacin?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 300, 2001-01 ,pp. :
ICDs: better QOL than amiodarone in ventricular arrhythmias
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 381, 2002-01 ,pp. :